ECSP003471A - SULFOHIDROXAMIC AROMATIC ACID METALOPROTEASE INHIBITOR - Google Patents

SULFOHIDROXAMIC AROMATIC ACID METALOPROTEASE INHIBITOR

Info

Publication number
ECSP003471A
ECSP003471A ECSP003471A ECSP003471A EC SP003471 A ECSP003471 A EC SP003471A EC SP003471 A ECSP003471 A EC SP003471A EC SP003471 A ECSP003471 A EC SP003471A
Authority
EC
Ecuador
Prior art keywords
inhibitor
sulfohidroxamic
metaloprotease
aromatic acid
metalloprotease
Prior art date
Application number
Other languages
Spanish (es)
Inventor
John Freskos
Terri L Boehm
Daniel Getman
Stephen A Kolodziej
Hui Yin Li
Thomas Barta
Daniel P Becker
Louis Bedell
Jeffrey N Carroll
Gary A Decrescenzo
Yvette M Fobian
Joseph J Mcdonald
Robert M Heintz
Susan C Howard
Joseph G Rico
Nathan W Stehle
Michael B Tollefson
William F Vernier
Susan L Hockerman
Brent V Mischke
Clara I Villamil
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003471 priority Critical patent/ECSP003471A/en
Publication of ECSP003471A publication Critical patent/ECSP003471A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

El presente invento está dirigido a un proceso de tratamiento que comprende la administración y observación de un inhibidor metaloproteasa sulfo ácido hidroxámico aromático en una eficiente cantidad a un mamífero anfitrión que tenga una condición asociada con una actividad patológica metaloproteasa.The present invention is directed to a treatment process comprising administering and observing a metalloprotease sulfo aromatic hydroxamic acid inhibitor in an efficient amount to a host mammal having a condition associated with pathological metalloprotease activity.

ECSP003471 2000-05-12 2000-05-12 SULFOHIDROXAMIC AROMATIC ACID METALOPROTEASE INHIBITOR ECSP003471A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003471 ECSP003471A (en) 2000-05-12 2000-05-12 SULFOHIDROXAMIC AROMATIC ACID METALOPROTEASE INHIBITOR

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003471 ECSP003471A (en) 2000-05-12 2000-05-12 SULFOHIDROXAMIC AROMATIC ACID METALOPROTEASE INHIBITOR

Publications (1)

Publication Number Publication Date
ECSP003471A true ECSP003471A (en) 2000-10-24

Family

ID=42041097

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003471 ECSP003471A (en) 2000-05-12 2000-05-12 SULFOHIDROXAMIC AROMATIC ACID METALOPROTEASE INHIBITOR

Country Status (1)

Country Link
EC (1) ECSP003471A (en)

Similar Documents

Publication Publication Date Title
IL134164A0 (en) Gaba analogs to prevent and treat gatrointestinal damage
NO20015543D0 (en) Aromatic sulfonic hydroxamic acid metalloprotease inhibitor
DE69828783D1 (en) HYDROXAMIC ACID SULFONAMIDE DERIVATIVES WITH AMIDATED AROMATIC RING
PL350193A1 (en) Sulfamato hydroxamic acid metalloprotease inhibitor
NO20054369L (en) Use of an IBAT inhibitor for the treatment and prophylaxis of constipation
NO20002469L (en) Aromatic sulfonic hydroxamic acid metalloprotease inhibitor
DE69905938D1 (en) COMBINATION OF DULOXETIN WITH NON-STEROID INFLAMMATORY INHIBITORS FOR THE TREATMENT OF PAIN
EP0983258A4 (en) N-HYDROXY-4-SULFONYL-BUTANAMIDE COMPOUNDS
ECSP034839A (en) SULFONA-AROMATIC HYDROXAMATES AND ITS USE AS PROTEASE INHIBITORS
MXPA04004803A (en) Aromatic sulfone hydroxamic acids and their use as protease inhibitors.
AR038437A1 (en) PERMANENT HAIR DYING IN TWO STEPS
PT1326853E (en) NEW TIADIAZOLES AND OXADIAZOLES AND ITS USE AS FOSFODIESTERASE-7 INHIBITORS
EA200101089A1 (en) NEW METHOD OF TREATMENT
EA200201175A1 (en) USE OF IL-18 INHIBITORS FOR THE TREATMENT AND / OR PREVENTION OF ATHEROSCLEROSIS
NZ515197A (en) Hydroxamic acid derivatives useful as matrix metalloprotease inhibitors
UY26474A1 (en) AMINO ACID DEPENDENT INHIBITORS FOR BRANCHED CHAIN AMINO ACIDS, AND THEIR USE IN THE TREATMENT OF DIABETIC RETINOPATHY.
EP1294411A4 (en) NEW TREATMENT AGAINST COUGH
MX9805290A (en) USE OF RETINOIC ACID ACTIVITY INHIBITORS TO TREAT SENSITIVE SKIN AND / OR ACUTE DAMAGE INDUCED BY ULTRAVIOLET RADIATION.
ECSP003471A (en) SULFOHIDROXAMIC AROMATIC ACID METALOPROTEASE INHIBITOR
NO20024481D0 (en) Difluorobutyric acid metalloprotease inhibitors
SE0301883D0 (en) New use II
UY26648A1 (en) VASOPEPTIDASE INHIBITORS TO TREAT ISOLATED SYSTOLIC HYPERTENSION
MXPA05010800A (en) Hydroxamic acids useful in the treatment of hyper-proliferative disorders.
EP0974351A3 (en) Medicament for preventing and treating gastrointestinal damage
FR2818412B1 (en) INTERACTIVE SYSTEM FOR IMPROVING SALES, PRODUCTION AND MANAGEMENT OF DETAIL SALES POINTS, IN PARTICULAR IN RAPID RESTORATION